To study thyroid hormone and estrogen interactions in the central nervous system (CNS), the expression of estrogen sensitive genes was examined within the limbic-hypothalamic circuit. Estrogen upregulates the expression of reproductively relevant neuropeptide messenger RNAs (mRNAs) encoding cholecystokinin (CCK) and enkephalin, peptides that stimulate lordosis. Estrogen down-regulates the expression of the estrogen receptor ␣ (ER␣) mRNA in the nuclei of the circuit. We examined the possibility that thyroid hormone treatment would block the estrogen modulation of these messages. Estradiol benzoate (EB), EB ϩ thyroxine (T 4 ), T 4 , or oil were administered to ovariectomized, adult female rats for 10 days. Isotopic in situ hybridization histochemistry revealed that within the limbichypothalamic nuclei, levels of CCK and preproenkephalin (PPE) mRNA levels were significantly higher in EB and EB ϩ T 4 -treated animals compared with T 4 or oil-treated animals. ER␣ mRNA levels were low in EB treated animals, elevated in T 4 or oil-treated animals and further elevated in EB ϩ T 4 -treated animals. In summary, T 4 treatment had neither an independent nor an antagonistic effect on estrogen induced expression of CCK or PPE mRNA in the circuit. However, T 4 did prevent the normal estrogenic decrease of ER␣ mRNA levels in the nuclei of the limbic-hypothalamic circuit. (Endocrinology 139: [1221][1222][1223][1224][1225][1226][1227][1228] 1998) H ORMONES communicate information regarding the overall physiological status of the animal to pertinent target sites, one of which is the central nervous system (CNS). Estrogen and thyroid hormones convey very different, but critical, information to the CNS. Estrogen primarily conveys reproductively relevant information that influences the function of the hypophyseal-pituitary-gonadal axis and regulation of the limbic-hypothalamic circuit, which is the neural substrate for the display of the female sexual receptive behavior, lordosis. In the adult female rat, an hormonal event essential for reproduction is the peaking of serum estrogen levels every 4 days of the estrous cycle. In concert with other hormonally mediated events, ovulation is coordinated with the display of lordosis behavior, thereby dramatically increasing the potential for successful fertilization. Thyroid hormones convey information relevant to the metabolic status of the animal and influence the rate of cellular glucose metabolism. Thyroid hormone secretion is dependent upon environmental variables, and serum levels are elevated in response to environmentally unfavorable conditions including decreasing ambient temperature and food availability (1), thus communicating potentially stressful metabolic constraints.
H ORMONES communicate information regarding the overall physiological status of the animal to pertinent target sites, one of which is the central nervous system (CNS). Estrogen and thyroid hormones convey very different, but critical, information to the CNS. Estrogen primarily conveys reproductively relevant information that influences the function of the hypophyseal-pituitary-gonadal axis and regulation of the limbic-hypothalamic circuit, which is the neural substrate for the display of the female sexual receptive behavior, lordosis. In the adult female rat, an hormonal event essential for reproduction is the peaking of serum estrogen levels every 4 days of the estrous cycle. In concert with other hormonally mediated events, ovulation is coordinated with the display of lordosis behavior, thereby dramatically increasing the potential for successful fertilization. Thyroid hormones convey information relevant to the metabolic status of the animal and influence the rate of cellular glucose metabolism. Thyroid hormone secretion is dependent upon environmental variables, and serum levels are elevated in response to environmentally unfavorable conditions including decreasing ambient temperature and food availability (1), thus communicating potentially stressful metabolic constraints.
A number of studies have examined the influence of estrogen and thyroid hormone interactions on reproduction. Studies using a variety of rodent species have demonstrated that food deprivation and cold exposure influence reproductive function as measured by: estrous cyclicity, display of reproductive behavior, litter size, and survival (1) (2) (3) (4) (5) (6) . Because serum thyroid hormone levels have been found to be elevated under these unfavorable environmental circumstances, thyroid hormones have been proposed to dampen estrogenic induction of the metabolically expensive process of sexual reproduction. Interactions between environmental stressors that alter thyroid hormone levels and reproduction are species specific (7, 8) . For example, the reproductive success of hamsters and guinea pigs is more sensitive to environmental manipulations (2, 6, 7) , than that of mice or rats (3, 4, 9) .
An important event in the estrogenic regulation of lordosis behavior is the induction of neuropeptide gene transcription [as measured by messenger RNA (mRNA) expression] in the limbic-hypothalamic circuit. This neural circuit is composed of several steroid concentrating, interconnected cell groups, including the principal portion of the bed nucleus of the stria terminalis (BSTp), central portion of the medial preoptic nucleus (MPNc), ventrolateral portion of the ventromedial nucleus of the hypothalamus (VMHvl), and the posterodorsal part of the medial amygdaloid nucleus (MeApd) (for review see Ref. 10) . The expression of cholecystokinin (CCK) and preproenkephalin (PPE; the precursor to enkephalin peptides) mRNA in the circuit have been demonstrated to be estrogen dependent. Ovariectomy reduces and estrogen replacement increases the expression of CCK and PPE mRNA in nuclei of the circuit (11, 12) . In contrast, estrogen inversely regulates the expression of the estrogen receptor ␣ (ER␣). Ovariectomy increases and estrogen treatment decreases the expression of ER␣ mRNA and protein in the nuclei of the circuit (13) (14) (15) (16) . Further, ER␣, CCK, and enkephalin peptides all dramatically impact the display of lordosis behavior. Antagonism of ER with tamoxifen prevents the estrogenic regulation of reproductively relevant genes, and therefore the display of lordosis behavior is inhibited (17) . In the MPN, CCK facilitates lordosis behavior but inhibits lordosis in the VMH (18 -20) . Also, enkephalin acting in the VMH and midbrain central gray has been implicated in regulation of lordosis (21) (22) (23) . Because estrogen normally up-regulates the mRNA of the reproductively relevant neuropeptide mRNAs and down-regulates ER␣ mRNA, we examined the possibility that, in the hyperthyroid condition, the estrogenic modulation of these reproductively important molecules would be antagonized. Such an antagonism of estrogenic actions in the limbic-hypothalamic circuit would implicate thyroid hormone as a transducing agent of environmental effects on reproduction.
Materials and Methods Animals
General. Adult Long-Evans female rats (75-90 days old; Charles River, Wilmington, MA) were ovariectomized by the supplier under ether anesthesia and were subsequently housed in the UCLA vivarium under a 12-h light, 12-h dark cycle with food and water available ad libitum. Animals were anesthetized with an ip injection of sodium pentobarbital (20 mg/100 g) before transcardial perfusion with saline and fixative. This protocol was approved by the UCLA Animal Research Committee and is in compliance with the NIH guidelines for vertebrate animal use.
Hormone treatments. To determine whether thyroid hormone treatment affects the estrogenic regulation of reproductively relevant mRNAs in the limbic-hypothalamic circuit, female rats were divided into four groups and injected with: 1) 17␤-estradiol 3-benzoate (EB; 2 g sc, daily; Sigma, St. Louis MO); 2) EB ϩ L-thyroxine (T 4 ; 250 mg/kg ip, twice daily; Sigma); 3) T 4 only or 4) oil vehicle for 10 days and were killed 24 h following the last hormone treatment (n ϭ 6/group). This dose of estrogen was chosen because it is not completely metabolized within 24 h, and therefore, slowly increases total serum estrogen over the course of the 10 day paradigm (11, 24) . The thyroid hormone dose was chosen since it has previously been shown to induce a hyperthyroid serum concentration (7, 24) .
Hybridization histochemistry
Tissue preparation. At the time the rats were killed, all animals were transcardially perfused with ice-cold physiological saline and 4% paraformaldehyde in 0.1 m Sö rensen's phosphate buffer. Brains were removed and postfixed in paraformaldehyde solution for 4 h at room temperature, then cryoprotected in 20% sucrose in PBS at 4 C for 24 h. Serial, coronal, 20-m-thick sections through the MPNc, VMHvl, and MeApd were obtained on a cryostat (Reichert, Deerfield, IL) and mounted onto Superfrost Plus slides (Fisher, Pittsburgh, PA). Slide mounted sections were desiccated and stored at Ϫ70 C until processing.
cRNA probes. CCK mRNA was localized using an 35 S-UTP labeled (Dupont-NEN, Boston, MA) single-stranded antisense complementary mRNA (cRNA) probe to the entire coding sequence of the rat CCK mRNA. The antisense probe was transcribed from a 527-bp CCK complementary DNA (cDNA) template (Dr. J. Dixon, University of Michigan, Ann Arbor, MI) using T7 RNA polymerase.
PPE mRNA was localized using an 35 S-UTP labeled single-stranded antisense cRNA probe complimentary to the entire coding sequence of the rat PPE-A mRNA. The antisense probe was transcribed from a 935 bp PPE-A cDNA template (Drs. Yoshikawa and Sabol, NIH, Bethesda, MD) using SP6 RNA polymerase.
ER␣ mRNA was localized using an 35 S-UTP labeled single-stranded antisense cRNA probe complimentary to a portion of the rat ER␣ mRNA (DNA binding and ligand binding domain coding region). The antisense probe was transcribed from an 820-bp ER␣ cDNA template (Dr. Muramatsu, University of Tokyo, Tokyo, Japan) using T7 RNA polymerase. At the hybridization temperature and wash stringency used in this study, this cRNA probe recognizes the mRNA for the ER␣ subtype (Norell and Micevych, unpublished observation).
In situ hybridization. The protocol used in this study was adapted from Abelson and Micevych, 1991 (25) . Alternate brain sections were processed for CCK, PPE, or ER␣ mRNA in situ hybridization histochemistry. Briefly, slide-mounted sections were brought to room temperature, rehydrated in diethylpyrocarbonate (DEPC)-treated PBS, and sequentially treated with predigested proteinase K (10 g/ml in 0.1 m Tris, 0.05 m EDTA, pH 8.0; 10 min at 37 C), DEPC-PBS, 0.1 m triethanolamine (TEA, pH 8.0; 2 min), acetic anhydride (0.25% in 0.1 m TEA; 10 min), and 2ϫ SSC (1ϫSSC ϭ 0.15 m NaCl, 0.04 m C 6 H 5 Na 3 O 7 , pH 7.2; 4 min) and were dehydrated in graded ethanols and xylene. Slides were air dried and incubated for 1 h with prehybridization buffer containing deionized formamide, 5ϫ hybridization salts (1ϫ hybridization salts ϭ 0.15 m NaCl, 5 mm EDTA, 5 mm PIPES, pH 6.8), 0.1 ϫ Denhardt's buffer (100 ϫ Denhardt's ϭ 2% each polyvinylpyrrolidone, Ficoll, and BSA), 0.2% SDS, 100 mm DTT, and 250 g/ml each of denatured salmon sperm and poly (A) ϩ RNA. For CCK mRNA in situ, slides were hybridized with 35 S-CCK cRNA probe (2.0 ϫ 10 6 cpm/3 ng/slide) and 40% formamide overnight at 60 C, as described (25) . For PPE mRNA in situ, slides were incubated with 35 S-PPE-A cRNA probe (1.5 ϫ 10 6 cpm/4 ng/slide) and 50% formamide overnight at 55 C, as described (12) . For ER␣ in situ, slides were incubated with 35 S-ER␣ cRNA probe (2.0 ϫ 10 6 cpm/3 ng/slide) and 40% formamide overnight at 60 C. Following hybridization, slides were immersed in 4ϫ SSC until coverslips floated off and were rinsed in fresh 4ϫ SSC. Sections were treated with RNase A (100 g/ml in 0.5 m NaCl, 10 mm Tris, 1 mm EDTA, pH 8.0) and washed in SSC solutions of increasingly higher stringencies containing 1 mm DTT to a final stringency of 0.1ϫ SSC (30 min at 55 C). Sections were then dehydrated in graded ethanols and xylene and air dried. Slides were dipped in Kodak NTB-2 nuclear emulsion (Kodak, Rochester, NY) diluted 1:1 with distilled water, and exposed at 4 C for 7 (PPE), 24 (ER), or 30 (CCK) days. Slides were developed using Kodak D-19 developer and fixer and were counterstained with toluidine blue, dehydrated, and coverslipped with Permount (Fisher).
Analysis. The boundaries of each nucleus were identified under brightfield optics, and the density of silver grains over each nuclear cell group was measured using darkfield optics and a computerassisted morphometric system (NIH Image, modified by Karl Beykirch, UCLA). Nonspecific background hybridization levels were determined by measuring the density of silver grains over an adjacent area of neuropil. For each nucleus, four to six sections evenly spaced through the rostro-caudal extent were analyzed from each animal. These values were used to calculate an mRNA labeling ratio (silver grain density of the specified nucleus/background density of silver grains) to express a relative level of CCK, PPE, or ER mRNA within a nucleus; a labeling ratio of one is equal to background levels of hybridization (11, 12) . The labeling ratio allows for comparison of hybridization of the same probe between slides within the same hybridization experiment and from different in situ hybridization experiments. If the specific activity of the probes are similar and within the linear range of the emulsion, the labeling ratio is independent of exposure time and emulsion thickness of the autoradiogram (for a detailed discussion see Ref. 26) . Additionally, labeling ratios of control areas were determined to ensure consistency between in situ hybridization experiments in nonestrogen-sensitive brain regions. For CCK mRNA, parietal cortex at the level of the MPN was examined; and for PPE-A mRNA, the striatum at the level of the VMH was evaluated. Comparisons of the data between treatment groups were made using one-way ANOVA and Student NewmanKeul's post hoc planned comparisons (Sigmastat, Jandel Scientific). Differences were considered statistically significant if P Ͻ 0.05. Figure 1 illustrates the CCK mRNA hybridization pattern in the MPNc after hormone treatment. In the MPNc of oiltreated (OVX) animals, CCK mRNA levels were low. T 4 treatment alone did not induce CCK mRNA labeling ratios compared with oil-treated animals (1.14 Ϯ 0.05 vs. 1.09 Ϯ 0.02). EB or EB ϩ T 4 treatment significantly induced CCK mRNA levels compared with oil-treated animals (labeling ratios: 2.10 Ϯ 0.06 or 2.96 Ϯ 0.22 vs. 1.09 Ϯ 0.02; Fig. 2A) . Additionally, EB ϩ T 4 -treated animals had CCK mRNA levels which were significantly higher than EB treated animals (labeling ratios: 2.96 Ϯ 0.22 vs. 2.10 Ϯ 0.06). In the MeApd of oil-treated animals, CCK mRNA labeling ratios were low. T 4 treatment alone did not induce CCK mRNA levels compared with oil-treated animals (1.55 Ϯ 0.12 vs. 1.20 Ϯ 0.07). EB or EB ϩ T 4 treatment significantly induced CCK mRNA levels compared with oil-treated animals (2.11 Ϯ 0.28 or 2.61 Ϯ 0.20 vs. 1.20 Ϯ 0.07). In this nucleus, levels of CCK mRNA were not significantly higher in EB ϩ T 4 compared with EB treated animals (2.61 Ϯ 0.28 vs. 2.11 Ϯ 0.28). In the cortex, CCK mRNA levels were statistically similar regardless of the treatments examined indicating a lack of EB, T 4 or a combined effect of these hormones on CCK mRNA levels in this brain region.
Results

CCK mRNA
PPE mRNA
In the MPNc of oil-treated animals, levels of PPE mRNA were low. T 4 treatment alone did not induce PPE mRNA labeling ratios compared with oil-treated animals (1.13 Ϯ 0.061. vs. 1.17 Ϯ 0.05; Fig. 2B ). EB or EB ϩ T 4 treatment significantly induced PPE mRNA levels compared with oil-treated animals (1.79 Ϯ 0.18 or 2.05 Ϯ 0.07 vs. 1.17 Ϯ 0.05). In the MeApd of oil-treated animals, PPE mRNA levels were low. T 4 treatment alone did not induce PPE mRNA labeling ratios compared with oil-treated animals (1.38 Ϯ 0.12 vs. Figures 3 and 4 illustrate the PPE mRNA hybridization pattern in the VMHvl following hormone treatment. In the striatum, PPE mRNA labeling ratios were statistically similar among all treatments indicating that these hormone treatments do not alter PPE mRNA levels in this brain region (Fig. 2B) .
Ϯ 0.19, respectively).
ER␣ mRNA
In contrast to the neuropeptide mRNA levels, the ER␣ mRNA labeling ratio in oil-treated animals were significantly elevated above the ratio in EB treated animals (Fig. 2C) . In the MPNc, T 4 treatment did not alter ER␣ mRNA expression compared with oil-treated animals (3.09 Ϯ 0.13 vs. 2.99 Ϯ 0.18). Treatment with EB significantly reduced mRNA levels (2.01 Ϯ 0.02 vs. 2.99 Ϯ 0.18), and EB ϩ T 4 significantly elevated ER mRNA levels compared ER␣ with oil-treated animals (3.81 Ϯ 0.09 vs. 2.99 Ϯ 0.18). In the MeApd, T 4 treatment did not alter ER␣ mRNA labeling ratios compared with oiltreated animals (3.32 Ϯ 0.13 vs. 3.37 Ϯ 0.10). EB treatment significantly reduced ER␣ mRNA levels compared with oiltreated animals (2.17 Ϯ 0.03 vs. 3.37 Ϯ 0.10). In this nucleus, EB ϩ T 4 treatment did not stimulate ER␣ the mRNA labeling ratio significantly compared with oil-treated animals (3.52 Ϯ 0.24 vs. 3.37 Ϯ 0.10), but levels were higher than those of EB-treated animals. In the VMHvl, T 4 treatment alone did not change ER␣ mRNA labeling ratios compared with oil-treated animals (4.01 Ϯ 0.09 vs. 3.86 Ϯ 0.05). EB treatment significantly reduced ER␣ mRNA labeling ratio (2.54 Ϯ 0.03 vs. 3.86 Ϯ 0.06), and EB ϩ T 4 significantly elevated ER␣ labeling ratio compared with oil-treated animals (4.75 Ϯ 0.16 vs. 3.86 Ϯ 0.06). Figure 5 illustrates the ER␣ mRNA hybridization pattern in the VMHvl following hormone treatments.
Discussion
The major findings of this study were as follows: 1) Thyroid hormone antagonized the estrogenic down-modulation of ER␣ mRNA within the circuit. ER␣ mRNA levels in the MPNc and VMHvl were higher after the combined estrogen and thyroid hormone treatment than in the control group, suggesting a thyroid hormone facilitation of ER␣ mRNA expression in EB treated rats. 2) Thyroid hormone had neither an independent nor an antagonistic effect on the estrogenic induction of CCK and PPE mRNA in the limbichypothalamic nuclei examined. Indeed, thyroid hormone potentiated the estrogenic effect on CCK mRNA expression in the MPNc. These results indicate that thyroid hormone would not likely antagonize reproductive behavior through a suppression of estrogen-induced CCK or PPE mRNA expression in the circuit.
The generally accepted pattern of ER␣ regulation in the brain is that increasing levels of estrogen down-regulate ER␣ mRNA, producing decreased levels of protein, binding sites, ER immunoreactive, and estrogen concentrating cells (13, (27) (28) (29) (30) (31) . This pattern is evident during the estrous cycle: ER␣ mRNA levels are lowest when estrogen titers are elevated, diestrus and proestrus, and highest when estrogen titers are lowest, estrus and metestrus (15, 16) . The close agreement between distribution and relative levels of ER␣ mRNA and protein indicate that measurement of message is a good predictor of ER␣ levels.
Despite these observations, there have been inconsistencies in the literature about which ER expressing cell groups respond to estrogen. For example, EB treatment has been reported to induce changes of estrogen receptors in the MPO but not the VMH, or vice versa (16, 27, 28, 30, 32) . The present study demonstrated a robust estrogen regulation of ER␣ mRNA throughout cell groups of the limbic-hypothalamic (15, 33) . The high levels of ER␣ mRNA in the MPNc, MeApd, VMHvl of OVX animals were reduced by treatment with EB (Fig. 2C) . Hence, the estrogen-induced down-regulation of its receptor message is a marker for estrogen action in the hypothalamic-limbic system. Because T 4 has been hypothesized as one of the endocrine signals suppressing reproduction in response to an adverse environment (24), we expected that the estrogen-induced decrease of ER␣ mRNA levels would be antagonized by T 4 treatment. Not only did T 4 prevent the estrogen-induced decrease of ER␣ mRNA levels from OVX levels, but animals treated with EB ϩ T 4 had higher levels of ER␣ mRNA compared with OVX animals. These results suggest that in the brain, elevated levels of T 4 potentiate ER mRNA levels in the presence of estrogen. Such an induction has been reported for ER␣ in pituitary and pituitary tumors, but not hypothalamus (32, 34) . This T 4 effect was thought to be mediated through an interaction of thyroid hormone receptor and ER␣. T 4 alone did not elevate ER␣ mRNA levels, suggesting that T 4 is not acting through a pathway separate from that activated by estrogen (35, 36) . Moreover, this potentiation of ER␣ mRNA in the MPNc and VMHvl was not observed in the MeApd, suggesting that EB ϩ T 4 interactions may be mediated through the synthesis and release of neuroactive compounds that have differential distributions and action in cell groups of the limbic-hypotha- lamic circuit. These regulatory compounds could interact with receptors and induce a cascade of intracellular events that result in alterations of estrogen-induced gene expression. For example, we have reported that endogenous opioids acting throught the ␦-opioid receptor attenuate the estrogen-induced expression of CCK mRNA (37) . Other transmitter-receptor systems have been implicated in the regulation of ER levels (38 -40) . T 4 influences many neuromodulatory systems implying a synaptic interaction, rather than an antagonistic interaction of thyroid receptor with the estrogen response element (41, 42) . For example, T 4 attenuates the EB-induced increase in D-2 dopamine receptors which appears to be secondary to T 4 blockade of estrogen inhibition of dopamine synthesis and release (43) .
Others have reported that T 4 -induced ER␣ immunoreactivity in the VMHvl above OVX levels (24) . It is difficult to reconcile these findings with the present report, which demonstrates that T 4 does not alter levels of ER mRNA in OVX animals, especially because levels of ER␣ immunoreactive cells in OVX animals reported by these authors was low in distinction to other reports (e.g. 27, 28). A possible explanation was that the H222 antiestrogen receptor antibody binds to ER␣ with greater affinity in the presence of high concentrations of T 4 . In fact, the number of ER␣ immunoreactive cells after T 4 treatment is similar to what others show in OVX, thyroid intact rats. Another possibility is that the H222 antibody recognizes both the ER␣ and the ER␤ subtypes (44) , and the receptor subtypes may be differentially modulated by T 4 . Several points mitigate against this as an explanation for the discrepancy of the results. First, in situ hybridization using a ER␤ riboprobe does not reveal specific hybridization in the VMH or MPN (45, Norell and Micevych, unpublished results). Second, the in situ hybridization conditions used in the present study allow identification of ER␣ mRNA but not ER␤ mRNA.
In this experiment, the antagonistic effects of T 4 on EB action were specific to ER␣ mRNA levels. T 4 did not interfere with estrogen's actions on levels of CCK or PPE mRNA, genes that are regulated transsynaptically and directly, respectively. CCK mRNA levels in the MPNc and MeApd were elevated by continuous EB treatment compared with low levels of expression in the absence of EB. This result is consistent with previous observations of CCK mRNA expression in the circuit after long- term, as well as acute, EB exposure (11) . T 4 treatment alone had no effect on CCK mRNA levels in these nuclei compared with oil-treated animals. Interestingly, EB ϩ T 4 treatment resulted in elevated levels of CCK mRNA in the MPNc compared with oil-treated animals, and hyperelevated levels in the MPNc compared with oil or EB treated animals. Such T 4 hormone potentiation of estrogen's action on gene expression has been reported; for example, Rabelo and Tata (46) have reported that T 4 treatment potentiated the EB activation of the vitellogenin gene in vitro, and in vivo, this treatment also increased the expression of ER␣ in hepatocytes.
The effects of estrogen and thyroid hormone treatment on PPE mRNA expression within the circuit was similar to that seen for CCK mRNA. PPE mRNA levels in the MPNc, MeApd, and VMHvl were elevated by EB treatment consistent with previous observations (12, (47) (48) (49) . Met-enkephalin immunoreactive neurons contain ER (50) and the PPE gene has a partial estrogen response element sequence (31), suggesting that estrogen directly regulates the expression of PPE mRNA. Thyroid hormone alone did not enhance PPE mRNA levels above levels in OVX animals and T 4 did not block the estrogen induction of PPE mRNA levels. Zhu et al. (51) , however, reported an elevation of PPE mRNA in the VMH with T 4 treatment compared with OVX control animals, and a reduction of PPE mRNA levels with EB ϩ T 4 treatment compared with EB treated animals. Unlike our results, the Zhu et al. (51) findings suggest an antagonism of the EB effect on PPE expression. Currently, it is difficult to explain these inconsistent results. One potential explanation for this inconsistency is the different techniques used in these studies. Zhu et al. used slot blot analysis to examine changes in PPE mRNA levels in the VMH. This technique is dependent upon consistent and discrete tissue microdissection of the VMH from neighboring nuclei and regions that also express PPE mRNA. For example, the arcuate nucleus and a band of PPE mRNA expressing cells extending dorsally from the VMHvl toward the fornix also express PPE mRNA in an estrogen dependent fashion, and therefore are a potential source of confoundance in slot blot analysis. In situ hybridization, in contrast, allows for the specific analysis of mRNA expression in a consistent, anatom- ically defined region. Therefore, it is particularly well suited in this instance for the analysis of the estrogen-thyroid hormone effect in the VMHvl, which would be difficult to dissect away from the remainder of the nucleus and from neighboring estrogen-sensitive PPE expressing cells, although we did not observe an upregulation of PPE mRNA levels after T 4 treatment in either of these adjacent areas.
Thyroid hormone did not alter the estrogen-induced expression of CCK and PPE mRNA within the circuit. These results do not preclude the possibility that the hyperinduced ER␣ mRNA and protein levels impact other molecules involved in the regulation of lordosis behavior. Therefore, provided other cellular processes such as mRNA stability, translation, and release are not impacted by T 4 treatment, these neuropeptide mRNA patterns indicate that an estrogenprimed hyperthyroid female may not be completely compromised in its display of reproductive behavior. This was demonstrated in a behavioral study done using the same hormone paradigm (24) . EB ϩ T 4 animals had lordosis frequencies higher than the OVX or T 4 groups but lower than EB-treated animals (24) . Our results are consistent with these behavioral data (24): oil or thyroid hormone treatment did not induce CCK or PPE mRNA and do not facilitate lordosis. Treatment with EB or EB ϩ T 4 stimulates the expression of mRNA coding for CCK and enkephalin which facilitate lordosis behavior. Because EB-induced down-regulation of ER␣ mRNA is correlated with behavioral receptivity, we speculate that the hyperinduction ER␣ mRNA in EB ϩ T 4 animals may offer an explanation for the attenuation of lordosis behavior. As mentioned above, T 4 may affect cellular processes that impact the translation of the mRNA to functional molecules or modulate receptors within the circuit. Alternatively, high levels of ER␣ mRNA (and presumably protein) in combination with, or resulting from T 4 treatment may act to prevent the estrogenic down-modulation of functionally inhibitory signals within the circuit, thereby attenuating the display of lordosis behavior.
Regardless of the mechanisms involved, these experiments do indicate that reproductively relevant molecules in nuclei of the lordosis regulating circuit are modulated by estrogen and thyroid hormone. The finding that thyroxine does not antagonize the estrogen-induced expression of CCK or PPE mRNA, but rather potentiates its effects, and that T 4 treatment moderately attenuates the estrogen induced ex- pression of lordosis behavior (24) , suggests that thyroid hormone actions at the level of the limbic-hypothalamic circuit are not sufficient to account for the reported effect of thyroid hormone suppression of reproductive events.
